Oxaliplatin-induced lung fibrosis
Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is manageable. However, rare, isolated cases of pulmonary fibrosis induced by this drug have been reported in literature. We report one such ca...
Saved in:
| Main Authors: | Shah Arpan, Udwadia Zarir, Almel Sachin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2009-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2009;volume=30;issue=3;spage=116;epage=118;aulast=Shah |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
by: Naza Shakir Shareef Shekhany, et al.
Published: (2023-06-01) -
Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01) -
Multi-Pathway Study for Oxaliplatin Resistance Reduction
by: Tong Ye, et al.
Published: (2025-03-01) -
Effects of Topical Capsaicin for Chemotherapy-Induced Peripheral Neuropathy (CIPN) Prophylaxis in Oxaliplatin-Treated Cancer Patients: A Double-Blind Randomized Clinical Trial
by: Nadia Najafizade, et al.
Published: (2025-05-01) -
Oxaliplatin-Loaded Chitosan Nanoparticles Decorated with Cetuximab Single-Chain Variable Fragment for Human Colorectal Cancer Treatment
by: Khadijeh Falahzadeh, et al.
Published: (2024-09-01)